micafungin + caspofungin
Phase 3Completed 3 views this week 0 watching⚡ Active
Interest: 40/100
40
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Candidiasis, Oral
Conditions
Candidiasis, Oral
Trial Timeline
Jun 1, 2004 → Dec 1, 2004
NCT ID
NCT00665639About micafungin + caspofungin
micafungin + caspofungin is a phase 3 stage product being developed by Astellas Pharma for Candidiasis, Oral. The current trial status is completed. This product is registered under clinical trial identifier NCT00665639. Target conditions include Candidiasis, Oral.
What happened to similar drugs?
5 of 20 similar drugs in Candidiasis, Oral were approved
Approved (5) Terminated (4) Active (12)
Hype Score Breakdown
Clinical
17
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (2)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00105144 | Phase 3 | Completed |
| NCT00665639 | Phase 3 | Completed |
Competing Products
20 competing products in Candidiasis, Oral
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| Micafungin | Astellas Pharma | Phase 1 | 29 |
| Isavuconazole + Caspofungin + Voriconazole | Astellas Pharma | Phase 3 | 40 |
| Micafungin + fluconazole | Astellas Pharma | Phase 3 | 40 |
| Micafungin (Mycamine) | Astellas Pharma | Phase 1 | 29 |
| Fluconazole + Micafungin | Astellas Pharma | Approved | 35 |
| Micafungin + Caspofungin | Astellas Pharma | Phase 3 | 40 |
| Micafungin + Fluconazole | Astellas Pharma | Phase 3 | 40 |
| Micafungin | Astellas Pharma | Phase 2 | 35 |
| micafungin + amphotericin B deoxycholate | Astellas Pharma | Phase 3 | 32 |
| FK463 | Astellas Pharma | Phase 2 | 35 |
| Micafungin + Liposomal Amphotericin B | Astellas Pharma | Phase 3 | 40 |
| SHR8008 + Fluconazole | Jiangsu Hengrui Medicine | Phase 3 | 36 |
| SHR8008 capsule + Fluconazole capsule | Jiangsu Hengrui Medicine | Phase 3 | 36 |
| L-743,872 | Merck | Pre-clinical | 26 |
| Caspofungin | Merck | Phase 2 | 35 |
| L-743,872 | Merck | Phase 2 | 27 |
| Caspofungin + Amphotericin B Deoxycholate | Merck | Phase 2 | 27 |
| Caspofungin acetate + Placebo | Merck | Phase 2 | 27 |
| Caspofungin + Normal Saline | Merck | Approved | 43 |
| caspofungin acetate | Merck | Phase 3 | 40 |